Back to results
US 2001/0034059 A1Published application
Homologs of SCF ubiquitin-ligase complex component GRR1
OwnerStephen M. Allen, Timothy G. Helentjarisinventors
Life of this patent
Estimating the term…
Abstract
This invention relates to an isolated nucleic acid fragment encoding a GRR1 homolog. The invention also relates to the construction of a chimeric gene encoding all or a portion of the GRR1 homolog, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the GRR1 homolog in a transformed host cell.
Claims24
An isolated polynucleotide comprising:
- (a) a first nucleotide sequence encoding a first polypeptide comprising at least 50 amino acids, wherein the amino acid sequence of the first polypeptide and the amino acid sequence of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:8, or SEQ ID NO:12 have at least 70% identity based on the Clustal alignment method,
- (b) a second nucleotide sequence encoding a second polypeptide comprising at least 100 amino acids, wherein the amino acid sequence of the second polypeptide and the amino acid sequence of SEQ ID NO:16 have at least 80% identity based on the Clustal alignment method,
- (c) a third nucleotide sequence encoding a third polypeptide comprising at least 100 amino acids, wherein the amino acid sequence of the third polypeptide and the amino acid sequence of SEQ ID NO:18 have at least 85% identity based on the Clustal alignment method,
- (d) a fourth nucleotide sequence encoding a fourth polypeptide comprising at least 250 amino acids, wherein the amino acid sequence of the fourth polypeptide and the amino acid sequence of SEQ ID NO:6, SEQ ID NO:10, or SEQ ID NO:20 have at least 70% identity based on the Clustal alignment method,
- (e) a fifth nucleotide sequence encoding a fifth polypeptide comprising at least 650 amino acids, wherein the amino acid sequence of the fifth polypeptide and the amino acid sequence of SEQ ID NO:14 have at least 70% identity based on the Clustal alignment method, or
- (f) the complement of the first, second, third, fourth, or fifth nucleotide sequence, wherein the complement and the first, second, third, fourth, or fifth nucleotide sequence contain the same number of nucleotides and are 100% complementary.
3 more elements
An isolated polypeptide comprising:
- (a) a first amino acid sequence comprising at least 50 amino acids, wherein the first amino acid sequence and the amino acid sequence of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:8, or SEQ ID NO:12 have at least 70% identity based on the Clustal alignment method,
- (b) a second amino acid sequence comprising at least 100 amino acids, wherein the second amino acid sequence and the amino acid sequence of SEQ ID NO:16 have at least 80% identity based on the Clustal alignment method,
- (c) a third amino acid sequence comprising at least 100 amino acids, wherein the third amino acid sequence and the amino acid sequence of SEQ ID NO:18 have at least 85% identity based on the Clustal alignment method,
- (d) a fourth amino acid sequence comprising at least 250 amino acids, wherein the fourth amino acid sequence and the amino acid sequence of SEQ ID NO:6, SEQ ID NO:10, or SEQ ID NO:20 have at least 70% identity based on the Clustal alignment method, or
- (e) a fifth amino acid sequence comprising at least 650 amino acids, wherein the fifth amino acid sequence and the amino acid sequence of SEQ ID NO:14 have at least 70% identity based on the Clustal alignment method.
2 more elements
Dependencies are inferred from the claim text.